To: | Novartis AG (mtepper@teiplaw.com) |
Subject: | U.S. Trademark Application Serial No. 90028312 - INFLAMMATION - N/A |
Sent: | November 05, 2020 10:08:40 AM |
Sent As: | ecom115@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90028312
Mark: INFLAMMATION
|
|
Correspondence Address: |
|
Applicant: Novartis AG
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: November 05, 2020
Application has been amended as shown below. As agreed to by Maury M. Tepper, III, Esq. on November 5, 2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id.
Amended Description of Mark
The following description of the mark replaces the current description of record:
The mark consists of a stylized human-like character with arms spread to either side, shadowed in gray, with orange, red and gold skin, gold and dark gold hair, gold, red and black eyes edged in purple, black eyebrows and a black mouth with white teeth, dressed in black pants with holes in the knees showing red skin beneath and a black vest and white shirt with the word “INFLAMMATION” written in red on the shirt. All other instances of the color white represents background and/or transparent areas and are not a feature of the mark.
See 37 C.F.R. §§2.37, 2.72; TMEP §§808 et seq.
/Sahar Nasserghodsi/
Sahar Nasserghodsi
Examining Attorney
Law Office 115
(571)272-9192
Sahar.Nasserghodsi@uspto.gov